Cargando…
Human iPSC-Derived 2D and 3D Platforms for Rapidly Assessing Developmental, Functional, and Terminal Toxicities in Neural Cells
With increasing global health threats has come an urgent need to rapidly develop and deploy safe and effective therapies. A common practice to fast track clinical adoption of compounds for new indications is to repurpose already approved therapeutics; however, many compounds considered safe to a spe...
Autores principales: | Slavin, Ileana, Dea, Steven, Arunkumar, Priyanka, Sodhi, Neha, Montefusco, Sandro, Siqueira-Neto, Jair, Seelke, Janet, Lofstrom, Mary Anne, Anson, Blake, Zanella, Fabian, Carromeu, Cassiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918576/ https://www.ncbi.nlm.nih.gov/pubmed/33672998 http://dx.doi.org/10.3390/ijms22041908 |
Ejemplares similares
-
Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids
por: Woodruff, Grace, et al.
Publicado: (2020) -
Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D
por: Jamieson, John J., et al.
Publicado: (2019) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014) -
Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018) -
iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)